Effective treatment of corticosteroid-induced facial erythema using fractional radiofrequency microneedling

IF 2.2 3区医学 Q2 DERMATOLOGY Lasers in Surgery and Medicine Pub Date : 2024-05-01 DOI:10.1002/lsm.23787

Xiaowen Huang PhD, Siqi Zheng MBBS, Pingjiao Chen PhD, Menghua Zhu MD, Jia Guo MD, Qian Li PhD, Kang Zeng PhD, Sijin He MD

{"title":"Effective treatment of corticosteroid-induced facial erythema using fractional radiofrequency microneedling","authors":"Xiaowen Huang PhD, Siqi Zheng MBBS, Pingjiao Chen PhD, Menghua Zhu MD, Jia Guo MD, Qian Li PhD, Kang Zeng PhD, Sijin He MD","doi":"10.1002/lsm.23787","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>To investigate the efficacy of Fractional Radiofrequency Microneedling (FRM) in treating corticosteroid-induced facial erythema.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A retrospective study was conducted involving eight patients diagnosed as corticosteroid-induced facial erythema. Each patient underwent a single session of FRM. Evaluative measures included Clinician's Erythema Assessment (CEA), Patient's Self-Assessment (PSA), assessment of telangiectasia severity, procedure-associated pain (10-point scale), patient satisfaction (3-point scale) and secondary outcomes.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The study found a 75% success rate and 100% effectiveness rate in alleviating erythema symptoms. CEA and PSA scores decreased by 67.7% and 78.1%, respectively. No cases of erythema rebound were recorded during the 3-month follow-up period.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>FRM demonstrated effectiveness and safety in treating facial erythema, offering promising advancement in dermatologic therapeutics.</p>\n </section>\n </div>","PeriodicalId":17961,"journal":{"name":"Lasers in Surgery and Medicine","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lasers in Surgery and Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/lsm.23787","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

To investigate the efficacy of Fractional Radiofrequency Microneedling (FRM) in treating corticosteroid-induced facial erythema.

Methods

A retrospective study was conducted involving eight patients diagnosed as corticosteroid-induced facial erythema. Each patient underwent a single session of FRM. Evaluative measures included Clinician's Erythema Assessment (CEA), Patient's Self-Assessment (PSA), assessment of telangiectasia severity, procedure-associated pain (10-point scale), patient satisfaction (3-point scale) and secondary outcomes.

Results

The study found a 75% success rate and 100% effectiveness rate in alleviating erythema symptoms. CEA and PSA scores decreased by 67.7% and 78.1%, respectively. No cases of erythema rebound were recorded during the 3-month follow-up period.

Conclusions

FRM demonstrated effectiveness and safety in treating facial erythema, offering promising advancement in dermatologic therapeutics.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

使用点阵射频微针有效治疗皮质类固醇引起的面部红斑

目的探讨点阵射频微针疗法（FRM）在治疗皮质类固醇引起的面部红斑方面的疗效。方法对 8 名确诊为皮质类固醇引起的面部红斑患者进行回顾性研究。每位患者都接受了一次 FRM 治疗。评估指标包括临床医师红斑评估（CEA）、患者自我评估（PSA）、毛细血管扩张严重程度评估、手术相关疼痛（10 分制）、患者满意度（3 分制）和次要结果。CEA和PSA评分分别下降了67.7%和78.1%。结论FRM 在治疗面部红斑方面表现出了有效性和安全性，是皮肤病治疗领域的一大进步。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Lasers in Surgery and Medicine 医学-外科

CiteScore

5.40

自引率

12.50%

发文量

119

审稿时长

1 months

期刊介绍： Lasers in Surgery and Medicine publishes the highest quality research and clinical manuscripts in areas relating to the use of lasers in medicine and biology. The journal publishes basic and clinical studies on the therapeutic and diagnostic use of lasers in all the surgical and medical specialties. Contributions regarding clinical trials, new therapeutic techniques or instrumentation, laser biophysics and bioengineering, photobiology and photochemistry, outcomes research, cost-effectiveness, and other aspects of biomedicine are welcome. Using a process of rigorous yet rapid review of submitted manuscripts, findings of high scientific and medical interest are published with a minimum delay.